Furthermore, the Apaf1 inhibitor has been used to confirm the effect of caspase-3 inhibition on GluR1 synaptic distribution in a mouse model of Alzheimer’s disease (D’Amelio et al., 2011). This evidence concerns the gene APAF1 and early-onset autosomal dominant Alzheimer disease.